Cost-Effective Synergy: 6-Month Clinical Trial Validates 200% Enhanced Fat Loss with EGCG & Garcinia Cambogia Formulation

Meta Description  

Clinically proven EGCG (98%) + Garcinia HCA(60%) blend delivers 200% greater fat reduction. Blue Eyes Biotech’snano-encapsulation solves stability & taste issues. Request samples fornutraceutical/cosmetic applications.  

TechnicalAbstract  

Blue Eyes Biotech introduces a patentedsynergistic formulation (BE-SYN025) of 98% epigallocatechin gallate (EGCG) and60% hydroxycitric acid (HCA) clinically proven to accelerate fat loss by 200%versus placebo in a 6-month RCT (n=150). Our proprietary nano-emulsionencapsulation technology overcomes key industry challenges: 1) Prevents EGCGdegradation (≥95% retentionat 40°C/6mo), 2)Masks HCA’s acidictaste without compromising 89% α-amylase inhibition activity. Dual-action efficacy is achieved throughAMPK pathway activation (EGCG) and ATP-citrate lyase inhibition (HCA), withMRI-confirmed visceral fat reduction of 18.7% (p<0.001).  

Scalable production via low-temperatureextrusion enables bulk ODM pricing at $105/kg (1-ton MOQ) – 35% below market –while maintaining >98% bioactive stability. Cross-industry applicationsinclude: 1) Nutraceuticals: Enteric-coated capsules showing 82% oralbioavailability; 2) Cosmeceuticals: Anti-adipogenic serums reducing lipidaccumulation by 63% in 3D skin models; 3) Functional Foods: pH-stable powderfor beverage fortification.  

Certified cGMP (21 CFR 111), FDA GRAS, andECOCERT Organic, the formulation complies with global regulatory standards.Strategic procurement benefits:  

- Free 3kg samples with clinicaldossier  

- Customized stability protocols (24-monthaccelerated data)  

- Turnkey solutions from formulation tocommercial batch production  

Download Clinical Report:[email protected] | www.blueeyes-bio.com